The role of nitric oxide in portal hypertensive systemic and portal vascular pathology

Acta Gastro-Enterologica Belgica

Volumn 60, Issue 3, 1997, Pages 222-232

  Hartleb, M ^a,c   Michielsen, P P ^b   Dziurkowska Marek, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c CSK   (Poland)

Author keywords

Hyperdynamic circulation; Nitric oxide; Portal hypertension

Indexed keywords

NITRIC OXIDE;

BLOOD VESSEL REACTIVITY; HUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; REVIEW; VASODILATATION;

ANIMALS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRCULATION; LIVER CIRRHOSIS; NITRIC OXIDE; PORTAL SYSTEM;

EID: 0030726305     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. GROSZMANN R.J Hemodynamic circulation of liver disease 40 years later : pathophysiology and clinical consequences Hepatology, 1994, 20 1359-63
2. MICHIELSEN P.P., PELCKMANS P.A. Haemodynamic changes in portal hypertension. new insights in the pathogenesis and clinical implications. Acta Gastroenterl Belg , 1994, 57 : 194-205.
3. FURCHGOTT R.F., ZAWADZKI J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288 : 373-6
4. MULVANY M J., HALPERN W Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ. Res., 1977, 41 : 19-26
5. LOSCALZO J , WELCH G Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis., 1995, 38 : 87-104
6. ROCKEY D The cellular pathogenesis of portal hypertension : Stellate cell contractility, endothelin and nitric oxide Hepatology, 1997, 25 : 2-5.
7. u-nitro-L-arginine : a potent inhibitor of endothelium-derived relaxing factor formation Eur. J. Pharmacol. 1990, 176 : 219-23.
8. GRIFFITHS M J , MESSENT M., MACALUSTER R.J , EVANS T W. Ammoguanidine selectively inhibits inducible nitric oxide synthase. Br. J Pharmacol., 1993, 110 : 963-8.
9. REES D D., CELLEK S., PALMER R.M., MONCADA S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone . an insight into endotoxin shock Biochem Biophys Res. Commun., 1990,173 : 541-7.
10. LINCOLN T.M., CORNWELL T.L. Intracellular cyclic GMP receptor proteins. FASEB J., 1993, 7 328-38.
11. MOREAU R , LEBREC D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol, 1995, 22 : 370-6.
12. CAO W.B , ZENG Z P., ZHU Y.J., LUO W.C., CAI B Q. Inhibition of nitric oxide synthesis increases the secretion of endothelin-1 in vivo and in cultured endothelial cells. Chin. Med J Engl, 1994, 107, 822-6.
13. CAHILL P.A, REDMOND E.M , FOSTER C., SITZMANN J.V Nitric oxide regulates angiotensin 11 receptors in vascular smooth muscle cells. Eur. J. Pharmacol., 1995, 288 . 219-29
14. RAVICHANDRAN L.V., JOHNS R.A , RENGASAMY A Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am. J Physiol, 1995, 268 : H2216-H2223
15. VALANCE P., MONCADA S. Hyperdynamic circulation in cirrhosis : role for nitric oxide? Lancet, 1991, 337 : 776-8
16. CAHILL P A., FOSTER C., REDMOND E.M , GINGALEWSKI C., WU Y, SITZMANN J V Enhanced nitric oxide synthase activity in portal hypertensive rabbits Hepatology, 1995, 22 : 598-606.
17. HORI N., TAKAHASHI H., OKANOUE T , SAWA Y., MORI T., TAKAMI S., YOSHIMURA M , KASHIMA K. Augmented endogenous nitric oxide production in partial portal vein-ligated rats J. Hepatol., 1995, 22: 250-1
18. HORI N., TAKAHASHI H., OKANOUE T., MORI T., SAKAMOTO S , NANBU A., YOSHIMURA M. Nitric oxide production in patients with chronic liver diseases Hepatology, 1993, 18 . 101A (abstract).
19. GUARNER C., SORIANO G , TOMAS A., BULBENA O., NOVELLA M.T., BALANZO J , VILARDELL F, MOURELLE M., MONCADA S. Increased serum nitrite and nitrate levels in patients with cirrhosis . relationship to endotoxemia. Hepatology, 1993, 18 : 1139-43.
20. CAMPILLO B , BORIES P.N., BENVENUTI C., DUPEYRON C. Serum and urinary nitrate levels in liver cirrhosis : endotoxemia, renal function and hyperdynamic circulation J. Hepatol., 1996, 24 : 707-14.
21. BATTISTA S., BAR F., MENGOZZI G , ZANON E , GROSSO M., MOLINO G. Hyperdynamic circulation in patients with cirrhosis : direct measurement of nitric oxide nitric oxide levels in hepatic and portal veins. J Hepalol., 1997, 26 . 75-80.
22. NIEDERBERGER M , GINES P., TSAI PH., MARTIN P.-Y., MORRIS K , WEIGERT A , MCMURTRY I , SCHRIER R.W. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats . evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology, 1995, 21 : 1625-31.
23. CAHILL P.A., REDMOND E M., HODGES R., ZHANG S , SITZMANN J.V. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J. Hepatol., 1996, 25 . 370-8.
24. KANWAR S., KUBES P., TEPPERMAN B.L., LEE S.S. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J. Hepalol., 1996, 25 85-9.
25. MORALES-RUIZ M., JIMENEZ W., PEREZ-SALA D., ROS J., LEIVAS A., LAMAS S , RIVERA F., ARROYO V. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology, 1996, 24 : 1481-86
26. MORALES M., JIMENEZ W, ROS J, LEIVAS A., PEREZ-SALA D., LAMAS S., ARROYO V , RIVERA F., RODES J. Transcriptional activation of inducible nitric oxide synthase in arterial vessels of cirrhotic rats Gastroenterology, 1995, 22 : A155 (abstract).
27. CLARIA J., JIMENEZ W., ROS J., ASBERT M., CASTRO A., ARROYO V., RIVERA F., RODES J. Pathogenesis of arterial hypotension in cirrhotic rats with ascites : role of endogenous nitric oxide. Hepatology, 1992, 15 : 343-9.
28. LEE F.Y., ALBILLOS A., COLOMBATO L.A., GROSZMANN R.J. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats Hepatology, 1992, 16 : 1043-8.
29. PIZCUETA M.P , PIQUE J M , BOSCH J , WHITTLE B.J., MONCADA S Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br. J. Pharmacol., 1992, 105, 184-190.
30. CAMPILLO B , CHABRIER P.-E , PELLE G., SEDIAME S , ATLAN G., FOUET P., ADNOT S. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology, 1995, 22 . 1421-9
31. LAFFI G., FOSCHI M , MASINI E., SIMONI A., MUGNAI L., LA VILLA G, BARLETTA G , MANNAIONI P F., GENTILINI P. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology, 1995, 22 : 1666-73.
32. SUFFREDINI A.F., FROMM R.E , PARKER M.M. The cardiovascular response of normal humans to the administration of endotoxin N. Engl. J. Mud , 1989, 321 : 280-7
33. OLD L.J. Tumor necrosis factor (TNF). Science, 1985, 230 : 630-2.
34. WERNER-FELMAYER G., WERNER E.R , FUCHS D., HAUSEN A., REIBNEGGER G , SCHMIDT K., WEISS G. Pteridine biosynthesis in human endothelial cells. J. Biol. Chem., 1993, 268 . 1842-6.
35. LE MOINE O., SOUPISON T , SOGNI P., MARCHANT A, MOREAU R., HADENGUE A., GOLDMAN M , DEVIERE J., LEBREC D Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis. J. Hepatol , 1995, 23 : 391-5.
36. FUKUI H., BRAUNER B., BODE J.C, BODE C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease . reevaluation with an improved chromogenic assay. J. Hepatol., 1991, 12 . 162-9
37. LIN R.S., LEE F.Y , LEE S.D. TSAI Y T, LIN H.C., LU R.H. Endotoxemia in patients with chronic liver disease relationship to severity of liver disease, presence of esophageal varices, and hyperdynamic circulation J Hepatol., 1995, 22 : 165-72
38. LUMSDEN A.B., HENDERSON J M., KUTNER M.H. Endotoxin Levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis Hepatology, 1988, 8 : 232-6.
39. TILG H., WILMER A., VOGEL W , HEROLD M., NOLCHEN B., JUDMAIRE G , HUBER O. Serum levels of cytokines in chronic liver diseases. Gastroenterology, 1992, 103 : 264-74.
40. BIGATELLO L M., BROITMAN S.A , FATTORI L Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J Gastroenterol., 1987, 82 11-5
41. LEE F.Y., LU R.H., TSAI Y.T., LIN H.C., HOU M C., LI C.P., LIAO T.M., LIN L F, WANG S S., LEE S.D Plasma interleukin-6 levels in patients with cirrhosis. Scand. J. Gastroenterol., 1996, 31 500-5.
42. BODE C , KUGLER V , BODE J.C, Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol, 1987, 4 8-14.
43. MICHIELSEN P.P., RAMON A.M., VAN ASSCHE K.J., PELCKMANS P.A. Circulating endotoxins and tumor necrosis factor α levels in portal vein ligated rats. Eur. J Clin Invest., 1996, 26. (suppl.I). A45 (abstract)
44. MEHTA R , GOTTSTEIN J, ZELLER W P , LICHTENBERG R , BLEI A.T. Endotoxin and the hyperdynamic circulation of portal veinligated rats. Hepatology, 1990, 12 . 1152-6
45. GARCIA-TSAO, LEE F.Y., BARDEN G.E , CARTUN R., WEST A.B. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology, 1995, 108 : 1835-41
46. SORELL W.T., QUIGLEY E.M., JIN G., JOHNSON T.J , RIKKERS L.F. Bacterial translocation in the portal-hypertensive rat . studies in basal conditions and on exposure to hemorrhagic shock Gastroenterology, 1993, 104: 1722-6.
47. LOPEZ-TALAVERA J.C , MERRILL W.W., GROSZMANN R.J. Tumor necrosis factor α : a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology, 1995, 108 : 761-7.
48. LOPEZ-TALAVERA J.C, CADELINA G., OLCHAWSKI J., MERRILL W., GROSZMANN R.J Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic cicrculatory syndrome in portal-hypertensive rats. Hepatology, 1996, 23 1616-21.
49. NIEDERBERGER M , MARTIN P Y , GINES P., MORRIS K , TSAI PH, XU D.L., MCMURTRY I., SCHRIER R.W. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology, 1995, 109 : 1624-30.
50. TANOUE K., OHTA M., TARNAWSKI A.S , WAHLSTROM K.J , SUGIMACHI K , SARFEH I J. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology, 1996, 110 : 549-57
51. ATUCHA N M., LOPEZ-TALAVERA J C., GARCIA-ESTAN J., GROSZMANN R.J Chronic arninoguanidine treatment improves the in vitro vascular hyporeactivity of portal hypertensive rats. Hepatology, 1994, 20 : 100 A (abstract)
52. LOPEZ-TALAVERA J C., GROSZMANN R J Treatment with aminoguanidine, a specific inhibitor of the inducible nitric oxide synthase, ameliorates the hyperdynamic syndrome in portal hypertensive rats Hepatology, 1994, 20 : 143 A (abstract)
53. LEE F.Y , WANG S S., TSAI Y T., LIN H.J , LIN H.C., CHU C.J., WU S.L., TAI C.C., LEE S.D Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats J. Hepatol., 1997, 26 : 687-96.
54. MICHIELSEN P.P., BOECKXSTAENS G.E., SYS S U , HERMAN A.G., PELCKMANS P.A. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein ligated rats. Eur J Pharmacol , 1997 (in press).
55. FERNANDEZ M., GARCIA PAGAN J.C., CASADEVALL M., BERNADICH C., PIERA C., WHITTLE B.J.R., PIQUE J.M., BOSCH J , RODES J. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology, 1995, 108 1487-95.
56. WEIGERT A., MARTIN P.Y , NIEDEBERGER M , HIGA E.M , MCMURTRY I.F., GINES P , SCHRIER R W. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats Hepatology, 1995, 22 : 1856-62
57. HEINEMANN A , STAUBLR R.E The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J. Pharmacol, 1995, 278 87-90.
58. KARATAPANIS S., MCCORMICK P A., KADAD S., CHIN J.K , ISLAM M., JEREMY J., HARRY D., MCINTYRE N., BURROUGHS A.K., JACOBS M Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology, 1994, 20 : 1516-21.
59. MICHIELSEN P P., BOECKXSTAENS G E , SYS S.U., HERMAN G , PELCKMANS PA Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats Eur. J . Pharmcol., 1995, 273 167-74
60. MICHIELSCN P.P., BOECKXSTAENS G.E , HERMAN A.G., PELCKMANS PA Acetylocholine-induced vasorelaxation in portal hypertensive rats. Hepatology, 1995, 22 . 1009-10.
61. CASTRO A , JIMENEZ W., CLARIA J., ROS J., MARTINEZ J.M., BOSCH M., ARROYO V., PIULATS J., RIVERA F., RODES J. Impaired responsiveness to angiotensin II in experimental cirrhosis : role of nitric oxide. Hepatology, 1993, 18 : 367-72.
62. MATHIE R.T., RALEVIC V., MOORE K.P., BURNSTOCK G. Mesenteric vasodilator responses in cirrhotic rats : a role for nitric oxide? Hepatology, 1996, 23 130-6.
63. CLARIA , JIMENEZ W., ROS J., RIGOL M , ANGELI P., ARROYO V, RIVERA F., RODES J. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites Hepatology, 1994, 20 : 1615-21.
64. GARCIA-ESTAN J., ATUCHA N M , SABIO J.M., VARGAS F., QUESADA T, ROMERO J.C. Increased endothelium-dependent renal vasodilation in cirrhotic rats. Am J. Physiol, 1994, 267 : R549-53.
65. ALBILLOS A., ROSSI I, CACHO G., MARTINEZ M.V., MILLAN I., ABREU L , BARRIOS C., ESCARTIN P. Enhanced endothelium-dependent vasodilation in patients with cirrhosis Am J. Physiol., 1995, 268 : G459-64.
66. CAHILL P A., WU Y , SITZMANN J.V. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits J. Clin Invest., 1994, 93 . 2691-700
67. ATUCHA N.M , SHAH V., GARCIA-CARDENA G., SESSA WE., GROSZMANN R J. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology, 1996, 111 : 1627-32.
68. SOGNI P., SMITH A.P.L , GADANO A., HIGENBOTTAM T.W., LEBREC D. NO synthases mRNA expression in thoracic aorta of cirrhotic rats : application of a non-radioactive quantitative RT-PCR method. J. Hepatol., 1996, 25 : A90 (abstract).
69. HENRIKSEN J H. Systemic haemodynamic alterations in hepatic cirrhosis. Eur. J Gastroenterol. Hepatol., 1991, 3 : 705-12.
70. SOGNI P , MOREAU R., OHSUGA M , GADANO A., LEBREC D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension J. Hepatol., 1995, 23 : 218-4
71. BOMZON A., BLENDIS L M. The nitric oxide hypothesis and the hyperdvnamic circulation in cirrhosis. Hepatology, 1994, 20 1343-50
72. BULT H , BOECKXSTAENS G.E., PELCKMANS P.A., JORDAENS F.H., VAN MAERCKE V.M., HERMAN A G. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter Nature, 1990, 345 346-7.
73. SIEBER C.C., GROSZMANN R.J Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats Gastroenterology, 1992, 103 : 235-9
74. SIEBER C C., LOPEZ-TALAVERA J.C., GROSZMANN R.J. Role of nitric oxide in the in vitro splanchnic vascular hyporeacivity in ascitic cirrhotic rats. Gastroenterology, 1993, 104 . 1750-4.
75. 1-adrenoceptors of portal hypertensive rats. Br J. Pharmacol, 1994, 111 439-44.
76. HARTLEB M., MOREAU R , GAUDIN C., LEBREC D. Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, .n rats with cirrhosis. J. Hepatol., 1995, 22 : 202-7.
77. MOREAU R., KOMEICHI H., KIRSTETTER P., OHSUGA M., CAILMAIL S., LEBREC D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis Gastroenterology, 1994, 106 . 1016-23.
78. SAFKA V., MOREAU R., GADANO A., LEBREC D Vascular hyporesponsiveness to vasodilators in rats with cirrhosis. J Hepatol , 1997, 26 . 382-6
79. HEINEMANN A , HORINA G., STAUBER R.E. Dilator responses to nitric oxide are enhanced in mesenteric arteries of portal hypertensive rats J. Hepatol , 1996, 25 90A (abstract)
80. SOGNI P., SABRY S , VIOREAU R , GADANO A., LEBREC D., DINH-XUAN A.T. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats J hepatol., 1996, 24 487-90
81. MICHIELSEN P P., BOECKXSTAENS G.E., SYS S.U., HERMAN G , PELCKMANS P A The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats J. Hepatol. 1995, 23 341-7
82. SIKULER E , GROSZMANN R J Hemodynamic studies in long- and short-term portal hypertensive rats : the relation to systemic glucagon levels. Hepatology, 1986, 6 . 414-8
83. PIZCUETA M P., PIQUE J.M , FERNANDEZ M , BOSCH J., WHITTLE B J , MONCADA S Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology, 1992, 103 : 1909-15.
84. PAICH D., MCCORMICK P.A , GREENSLADE L., DICK R., BURROUGHS A.K The effect of a niric oxide synthase inhibitor on systemic hemodynamics in cirrhotic patients. Gastroenterology, 1995, 108: A1144 (abstract).
85. SIEBER C., GROSZMANN R.J. In vitro hyporeactivity to methoxamine in portal hypertensive rats : reversal by nitric oxide blockade Am. J. Physiol., 1992, 262 : G996-1001.
86. SIEBER C.C., LEE F Y , GROSZMANN R J. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats. Hepatology, 1996, 23 : 1218-23.
87. TANOUE K., SARFEH I.J., TARNAWSKI A , WAHLSTROM K.J., IRWIN F.L., LEE J , NGUYEN T H , SUGIMACHI K, Overexpression of nitric oxide synthase gene and protein in portal hypertensive gastric mucosa. Gastroenterology, 1995,108: A1182 (abstract).
88. EL-NEWIHI H.M., KANJI V.K., MIHAS A.A. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am. J. Gastroenterol., 1996, 91 : 535-8.
89. CASADEVALL M , PIQUE J.M., CIRERA I , GOLDIN E., ELIZALDE I., PANES J., MARTINEZ-CUESTA M.A., BOSCH J., TERES J., RODES J. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. Gastroenterology, 1996, 110 1156-65
90. CIRERA J., PIQUE J.M., ELIZALDE I., FEU F., GARCIA-PAGAN J.C., GOLDIN E , CASADEVALL M , TERES J , BOSCH J., RODES J. Chronic anemia worsens the hyperdynamic circulation and increases the risk of GI-bleeding in patients with cirrhosis. Gastroenterology, 1995. 108 : A1050 (abstract).
91. FERRAZ J G.P , MCKNIGHT W , SHARKEY K A , WALLACE J.L. Impaired vasodilatory response in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis Gastroenterology, 1995, 108 1183-91
92. FERRAZ J G.P., WALLACE J.L. Prostaglandins modulate the responsiveness of the gastric microcirculation to sodium nitroprusside in cirrhotic rats Hepatology, 1996, 23 : 123-9.
93. CASADEVALL M., PANES J , PIQUE J M., MARRONI N., BOSCH J., WHITTLE B.J. Involvement of ntric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology, 1993, 18 . 628-34
94. FERNANDEZ M , GARCIA PAGAN J C., CASADEVALL M., MOURELLE M I., PIQUE J.M., BOSCH J , RODES J. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats : influence in nitric oxide biosynthesis Gastroenterology, 1996, 110 . 1529-35.
95. EPSTEIN M Hepatorenal syndrome : emerging perspectives of pathophysiology and therapy J Am. Soc Nephrol , 1994, 10 : 1735-53
96. ROS J., CLARIA J , JIMENEZ W., BOSCH-MARCE M., ANGELI P , ARROYO V., RIVERA F., RODES J Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology, 1995, 22 . 915-20.
97. GARCIA-ESTAN J., ATUCHA N M , GROSZMANN R.J. Renal response to methoxamine in portal hypertensive rats role of prostaglandins and nitric oxide. J Hepatol., 1996, 25 : 206-11.
98. WOJTAS R.P., HELLER J., IVEN D., SPENGLER U., SAUERBRUCH T Nitric oxide and renal functional reserve in compensated cirrhosis. Gastroenterology, 1995, 108 : A1199 (abstract).
99. u-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and sodium retention in portal hypertensive rats. Hepatology, 1993, 17 : 84-90
100. ROS J , JIMENEZ W., LAMAS S., CLARIA J , ARROYO V., RIVERA F., RODES J. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology, 1995, 21 : 554-60.
101. MCCORMICK P.A , CHIN J K T., NAIR D.R., SWENY P, KARATAPANIS S., VARGHESE Z , JACOBS M , MCINTYRE N., BURROUGHS A.K. Nitric oxide synthase inhibitors in the hepatorenal syndrome Eur J Gastroenterol. Hepatol., 1993, 5 : 59-60.
102. ATUCHA N.M., GARCIA-ESTAN J., RAMIREZ A , PEREZ M C , QUESODA T, ROMERO J C. Renal effect of nitric oxide synthesis inhibition in cirrhotic rats Am. J. Physiol., 1994, 267 R1454-60.
103. TAJIRI K , MIYAKAWA H., IZUMI N., MARUMO E, SATO C Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascitcs role of nitric oxide Hepatology, 1995, 22 : 1430-5.
104. ANGELI P., BORTOLUZZI A., CON R., VOLPIN R., CAMERIERO V., CRAIGHERO R., STICCA A., GATTA A Renal effects of Zaniprast, a cyclic guanosine monophosphate (cGMP) phosphodiesterase inhibitor, in cirrhotic rats with ascites. J. Hepatol., 1996, 25 : A72 (abstract).
105. CREMONA G., HIGENBOITAM T.W. MAYORAL V., ALEXANDER G., DEMONCHEAUX E., BORLAND C., ROE P., JONES G J. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome Eur. Respir J , 1995, 8 : 1883-5.
106. MATSUMOTO A., OGURA K., HITARA Y., KAKOKI M., WATANABE F., TAKENAKA K., SHIRATORI Y , MOMOMURA S., OMATA M Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern. Med , 1995, 123 : 110-3.
107. SOGNI P., GARNIER P , GADANO A , MOREAU R , DALLAVASANTUCCI, DINH-XUAN A.T., LEBREC D. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis J. Hepatol., 1995, 23 . 471-3.
108. ROLLA G., BUCCA C., BRUSSINO L. Methylene blue in the hepatopulmonary syndrome (letter). N Engl. J. Med., 1994, 331 : 1098.
109. VAN OBBERGH L., VALLIERES Y., BLAISE G. Cardiac modifications ocurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J. Hepatol., 1996, 24 : 747-52.
110. MATHIE R.T , RALEVIC V , MOORE K P., BURNSTOCK G Portal vascular responsiveness to sympathetic stimulation and nitric oxide in cirhotic rats J. Hepatol , 1996, 25 : 90-7.
111. ROCKEY D C, CHUNG J J. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility J. Clin. Invest., 1995, 95 : 1199-206.
112. ROCKEY D.C., CHUNG J.J. Regulation of inducible nitric oxide synthases during liver injury. Hepatology, 1995, 22 A249 (abstract).
113. ZIMMERMAN H., KURZEN P., KLOSSNER W., RENNER E.L., MARTI U Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledochojejunostomy in the rat. J. Hepotol, 1996, 25 : 567-73.
114. KLOSSNER W., ZIMMERMANN H , SAGESSER H., REICHEN J. Bile duct ligation induces portal hypertension via decreased hepatic nitric oxide synthase prior to formation of biliary cirrhosis in rats J. Hepaiol., 1996, 25 : 90A (abstract).
115. CUMMINGS S A , GROSZMANN R J , KAUMANN A.J. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br. J. Pharmac., 1986, 89 . 501-13.
116. GROSSMAN H.J., GROSSMAN V.L , BHATHAL P.S. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood J.Gastroenterol. Hepatol., 1992, 7 : 283-7.
117. LEE F.Y., COLOMBATO L A , ALBILLOS A , GROSZMANN R.J. Administartion of N omega-nitro-L-arginine ameliorates portal systemic shunting in portal-hypertensive rats. Gastroenterology, 1993, 105 1464-70.
118. MOSCA P , LEE F.-Y., KAUMANN A.J., GROSZMANN R.J. Pharmacology of portal-systemic collaterals in portal hypertensive rats : role of endothelium Am J. Physiol., 1992, 263 . G544-50.
119. ZICHE M., MORBIDELLI L., MASINI E., ANERINI S., GRANGER H.J., MAGGI C.A , GEPPETTI P , LEDDE F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin Invest., 1994, 94 : 2036-44.
120. GARCIA-PAGAN J C., FERNANDEZ M., BERNADICH C , PIZCUETA P , PIQUE J.M., BOSCH J., RODES J. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat Am. J. Physiol., 1995, 267 : G 9984-90
121. FORREST E.H , JONES A L , DILLON J.F., WALKER J., HAYES P.C The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis,. J. Hepatol., 1995, 23 : 254-8.
122. WU Y , BURNS R C., SITZMANN J.V. Effect of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension Hepatology, 1993, 18 . 1416-21.
123. SOGNI P., MOREAU R., OHSUGA M., CAILMAIL S , HADENGUE A., PUSSARD E , LEBREC D. Evidence for normal nitric-oxide vasodilator tone in conscious rats with cirrhosis Hepatology, 1992, 16 . 980-3.
124. IWAIA F., JOH T., KAWAI T, ITOH M. Role of EDRH in splanchnic blood flow of normal and chronic portal hypertensive rats Am J. Physiol., 1992, 263 : G149-G154
125. CAWLEY T, GERAGHTY J., OSBORNE H., DOCHERTY J.R. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Br J. Pharmacol., 1995, 114 . 791-6.